CMF (chemotherapy)

From Wikipedia, the free encyclopedia

Cyclophosphamide Methotrexate Fluorouracil (CMF) is a commonly used regimen of breast cancer chemotherapy.

It is named for the three medicines that comprise the therapy: cyclophosphamide, methotrexate, and 5-fluorouracil.[1]

[edit] References

  1. ^ Kimmick GG, Cirrincione C, Duggan DB, et al (2008). "Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944)". Breast Cancer Res. Treat.. doi:10.1007/s10549-008-9943-2. PMID 18306034. 
 This oncology article is a stub. You can help Wikipedia by expanding it.